EBA-175 RII-NG Malaria Vaccine Administered Intramuscularly in Semi-immune Adults

Clinical Trial ID NCT01026246

PubWeight™ 3.33‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01026246

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A review of malaria vaccine clinical projects based on the WHO rainbow table. Malar J 2012 1.87
2 Safety and Immunogenicity of EBA-175 RII-NG Malaria Vaccine Administered Intramuscularly in Semi-Immune Adults: A Phase 1, Double-Blinded Placebo Controlled Dosage Escalation Study. PLoS One 2016 0.75
3 Approaching the target: the path towards an effective malaria vaccine. Mediterr J Hematol Infect Dis 2012 0.75
Next 100